Cargando…

Longitudinal recovery patterns of penile length and the underexplored benefit of long-term phosphodiesterase-5 inhibitor use after radical prostatectomy

BACKGROUND: Penile length (PL) shortening is an underreported phenomenon following radical prostatectomy (RP) and risk factors are not fully explored. We aimed to describe longitudinal patterns of PL recovery and evaluate factors predicting complete return to baseline PL. METHODS: PL measurement was...

Descripción completa

Detalles Bibliográficos
Autores principales: Kwon, Young Suk, Farber, Nicholas, Yu, Ji Woong, Rhee, Kevin, Han, Christopher, Ney, Patrick, Hong, Jeong Hee, Lee, Paul, Gupta, Nikhil, Kim, Wun-Jae, Kim, Isaac Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5941788/
https://www.ncbi.nlm.nih.gov/pubmed/29739455
http://dx.doi.org/10.1186/s12894-018-0341-8
_version_ 1783321355865817088
author Kwon, Young Suk
Farber, Nicholas
Yu, Ji Woong
Rhee, Kevin
Han, Christopher
Ney, Patrick
Hong, Jeong Hee
Lee, Paul
Gupta, Nikhil
Kim, Wun-Jae
Kim, Isaac Yi
author_facet Kwon, Young Suk
Farber, Nicholas
Yu, Ji Woong
Rhee, Kevin
Han, Christopher
Ney, Patrick
Hong, Jeong Hee
Lee, Paul
Gupta, Nikhil
Kim, Wun-Jae
Kim, Isaac Yi
author_sort Kwon, Young Suk
collection PubMed
description BACKGROUND: Penile length (PL) shortening is an underreported phenomenon following radical prostatectomy (RP) and risk factors are not fully explored. We aimed to describe longitudinal patterns of PL recovery and evaluate factors predicting complete return to baseline PL. METHODS: PL measurement was performed during a preoperative and postoperative follow-up visits at 7 days and 3, 6, 9, and 12 months. Patients who completely recovered (CR: N = 397) their preoperative stretched PL measured during at least one of their follow-up visits were compared to those with incomplete recovery (IR: N = 131). Recovery patterns were analyzed for both groups and were also compared in regards to demographics, nerve-sparing techniques, prostate size, cardiovascular risk profiles, and phosphodiesterase-5 inhibitor (PDE5i) uses. Logistic regression analyses were performed using age and other relevant clinicopathologic variables to predict PL recovery. RESULTS: 60.2% of the total study population regained their preoperative PL at 12 months. Average percent (length) differences from baseline were − 1.70% (− 0.25 cm) and − 16.42% (− 2.35 cm) in the CR and the IR groups, respectively (p < 0.001). Multivariate logistic regression demonstrated that younger age (OR 0.962; 95%CI 0.931–0.994; p = 0.019), high preoperative erectile function (EF) (OR 1.028; 95%CI 1.001–1.056; p = 0.046), and consistent PDE5i use (OR 1.998; 95%CI 1.166–3.425; p = 0.012) were independent predictors of CR. At 12-month follow up, PL difference for consistent PDE5iusers was statistically different from those who did not use PDE5i consistently (− 3.25%vs. -6.64%; P = 0.001). CONCLUSION: Age, preoperative EF, and consistent use of PDE5i were associated with complete recovery of baseline PL after RP. The therapeutic effect of PDE5i was most pronounced at 12-month visit, suggesting an added benefit with long-term use. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12894-018-0341-8) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5941788
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-59417882018-05-14 Longitudinal recovery patterns of penile length and the underexplored benefit of long-term phosphodiesterase-5 inhibitor use after radical prostatectomy Kwon, Young Suk Farber, Nicholas Yu, Ji Woong Rhee, Kevin Han, Christopher Ney, Patrick Hong, Jeong Hee Lee, Paul Gupta, Nikhil Kim, Wun-Jae Kim, Isaac Yi BMC Urol Research Article BACKGROUND: Penile length (PL) shortening is an underreported phenomenon following radical prostatectomy (RP) and risk factors are not fully explored. We aimed to describe longitudinal patterns of PL recovery and evaluate factors predicting complete return to baseline PL. METHODS: PL measurement was performed during a preoperative and postoperative follow-up visits at 7 days and 3, 6, 9, and 12 months. Patients who completely recovered (CR: N = 397) their preoperative stretched PL measured during at least one of their follow-up visits were compared to those with incomplete recovery (IR: N = 131). Recovery patterns were analyzed for both groups and were also compared in regards to demographics, nerve-sparing techniques, prostate size, cardiovascular risk profiles, and phosphodiesterase-5 inhibitor (PDE5i) uses. Logistic regression analyses were performed using age and other relevant clinicopathologic variables to predict PL recovery. RESULTS: 60.2% of the total study population regained their preoperative PL at 12 months. Average percent (length) differences from baseline were − 1.70% (− 0.25 cm) and − 16.42% (− 2.35 cm) in the CR and the IR groups, respectively (p < 0.001). Multivariate logistic regression demonstrated that younger age (OR 0.962; 95%CI 0.931–0.994; p = 0.019), high preoperative erectile function (EF) (OR 1.028; 95%CI 1.001–1.056; p = 0.046), and consistent PDE5i use (OR 1.998; 95%CI 1.166–3.425; p = 0.012) were independent predictors of CR. At 12-month follow up, PL difference for consistent PDE5iusers was statistically different from those who did not use PDE5i consistently (− 3.25%vs. -6.64%; P = 0.001). CONCLUSION: Age, preoperative EF, and consistent use of PDE5i were associated with complete recovery of baseline PL after RP. The therapeutic effect of PDE5i was most pronounced at 12-month visit, suggesting an added benefit with long-term use. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12894-018-0341-8) contains supplementary material, which is available to authorized users. BioMed Central 2018-05-09 /pmc/articles/PMC5941788/ /pubmed/29739455 http://dx.doi.org/10.1186/s12894-018-0341-8 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Kwon, Young Suk
Farber, Nicholas
Yu, Ji Woong
Rhee, Kevin
Han, Christopher
Ney, Patrick
Hong, Jeong Hee
Lee, Paul
Gupta, Nikhil
Kim, Wun-Jae
Kim, Isaac Yi
Longitudinal recovery patterns of penile length and the underexplored benefit of long-term phosphodiesterase-5 inhibitor use after radical prostatectomy
title Longitudinal recovery patterns of penile length and the underexplored benefit of long-term phosphodiesterase-5 inhibitor use after radical prostatectomy
title_full Longitudinal recovery patterns of penile length and the underexplored benefit of long-term phosphodiesterase-5 inhibitor use after radical prostatectomy
title_fullStr Longitudinal recovery patterns of penile length and the underexplored benefit of long-term phosphodiesterase-5 inhibitor use after radical prostatectomy
title_full_unstemmed Longitudinal recovery patterns of penile length and the underexplored benefit of long-term phosphodiesterase-5 inhibitor use after radical prostatectomy
title_short Longitudinal recovery patterns of penile length and the underexplored benefit of long-term phosphodiesterase-5 inhibitor use after radical prostatectomy
title_sort longitudinal recovery patterns of penile length and the underexplored benefit of long-term phosphodiesterase-5 inhibitor use after radical prostatectomy
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5941788/
https://www.ncbi.nlm.nih.gov/pubmed/29739455
http://dx.doi.org/10.1186/s12894-018-0341-8
work_keys_str_mv AT kwonyoungsuk longitudinalrecoverypatternsofpenilelengthandtheunderexploredbenefitoflongtermphosphodiesterase5inhibitoruseafterradicalprostatectomy
AT farbernicholas longitudinalrecoverypatternsofpenilelengthandtheunderexploredbenefitoflongtermphosphodiesterase5inhibitoruseafterradicalprostatectomy
AT yujiwoong longitudinalrecoverypatternsofpenilelengthandtheunderexploredbenefitoflongtermphosphodiesterase5inhibitoruseafterradicalprostatectomy
AT rheekevin longitudinalrecoverypatternsofpenilelengthandtheunderexploredbenefitoflongtermphosphodiesterase5inhibitoruseafterradicalprostatectomy
AT hanchristopher longitudinalrecoverypatternsofpenilelengthandtheunderexploredbenefitoflongtermphosphodiesterase5inhibitoruseafterradicalprostatectomy
AT neypatrick longitudinalrecoverypatternsofpenilelengthandtheunderexploredbenefitoflongtermphosphodiesterase5inhibitoruseafterradicalprostatectomy
AT hongjeonghee longitudinalrecoverypatternsofpenilelengthandtheunderexploredbenefitoflongtermphosphodiesterase5inhibitoruseafterradicalprostatectomy
AT leepaul longitudinalrecoverypatternsofpenilelengthandtheunderexploredbenefitoflongtermphosphodiesterase5inhibitoruseafterradicalprostatectomy
AT guptanikhil longitudinalrecoverypatternsofpenilelengthandtheunderexploredbenefitoflongtermphosphodiesterase5inhibitoruseafterradicalprostatectomy
AT kimwunjae longitudinalrecoverypatternsofpenilelengthandtheunderexploredbenefitoflongtermphosphodiesterase5inhibitoruseafterradicalprostatectomy
AT kimisaacyi longitudinalrecoverypatternsofpenilelengthandtheunderexploredbenefitoflongtermphosphodiesterase5inhibitoruseafterradicalprostatectomy